1:2:1 Podcast

Mark Hlatky on statins

A major study recently showed that cholesterol-lowering drugs called statins can dramatically decrease the risk of heart attacks and strokes for millions more people. In an accompanying editorial in the New England Journal of Medicine, however, Mark Hlatky, MD, professor of health research and policy and of cardiovascular medicine, urged caution in the prescription of these drugs to seemingly healthy patients. He discusses the implications of the study's findings with the school's executive director of communications, Paul Costello.

Length: 22 mins. 57 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.